GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GemPharmatech Co Ltd (SHSE:688046) » Definitions » EV-to-FCF

GemPharmatech Co (SHSE:688046) EV-to-FCF : -24.81 (As of May. 26, 2024)


View and export this data going back to 2022. Start your Free Trial

What is GemPharmatech Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, GemPharmatech Co's Enterprise Value is ¥3,364.3 Mil. GemPharmatech Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-135.6 Mil. Therefore, GemPharmatech Co's EV-to-FCF for today is -24.81.

The historical rank and industry rank for GemPharmatech Co's EV-to-FCF or its related term are showing as below:

SHSE:688046' s EV-to-FCF Range Over the Past 10 Years
Min: -812.16   Med: -101.92   Max: -25.32
Current: -25.32

During the past 6 years, the highest EV-to-FCF of GemPharmatech Co was -25.32. The lowest was -812.16. And the median was -101.92.

SHSE:688046's EV-to-FCF is ranked worse than
100% of 372 companies
in the Biotechnology industry
Industry Median: 8.36 vs SHSE:688046: -25.32

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), GemPharmatech Co's stock price is ¥10.63. GemPharmatech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.380. Therefore, GemPharmatech Co's PE Ratio for today is 27.97.


GemPharmatech Co EV-to-FCF Historical Data

The historical data trend for GemPharmatech Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemPharmatech Co EV-to-FCF Chart

GemPharmatech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - - - -102.76 -80.44

GemPharmatech Co Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -124.78 -64.07 -51.82 -80.44 -31.55

Competitive Comparison of GemPharmatech Co's EV-to-FCF

For the Biotechnology subindustry, GemPharmatech Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GemPharmatech Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GemPharmatech Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where GemPharmatech Co's EV-to-FCF falls into.



GemPharmatech Co EV-to-FCF Calculation

GemPharmatech Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3364.284/-135.604
=-24.81

GemPharmatech Co's current Enterprise Value is ¥3,364.3 Mil.
GemPharmatech Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-135.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GemPharmatech Co  (SHSE:688046) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

GemPharmatech Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=10.63/0.380
=27.97

GemPharmatech Co's share price for today is ¥10.63.
GemPharmatech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.380.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


GemPharmatech Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of GemPharmatech Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


GemPharmatech Co (SHSE:688046) Business Description

Traded in Other Exchanges
N/A
Address
No. 12, Xuefu Road, Jiangbei New District, Jiangsu Province, Nanjing, CHN, 210032
GemPharmatech Co Ltd is a provider of?genetically engineered mouse?models?and services to global preclinical research and development communities. It specializes in developing animal models using cutting edge gene-editing technologies with a large collection of?cKO/KO (conditional knockout/knockout) mice, humanized mice, immunodeficient mice, and germ-free mice.

GemPharmatech Co (SHSE:688046) Headlines

No Headlines